MIRM Next Earnings Date Notes

— Mirum Pharmaceuticals (NASDAQ: MIRM) is a biopharmaceutical company focused on developing & commercializing therapies for rare liver diseases, particularly in pediatric populations. The company's flagship products are LIVMARLI (maralixibat) & CHOLBAM, both targeting cholestatic liver diseases such as Alagille syndrome (ALGS) & progressive familial intrahepatic cholestasis (PFIC). As you prepare for the next earnings date, key business metrics to follow include: (1) Net product revenue growth, especially for LIVMARLI's uptake in ALGS & PFIC indications, (2) patient expansion & prescription trends, both in the U.S. & international markets, and (3) pipeline progress, including clinical trial updates & regulatory milestones for new indications or labels. Keep an eye on gross margin trends & operating expense management, as Mirum continues to invest in commercial infrastructure while seeking global expansion. Important non-financial factors include FDA/EMA decisions, licensing deals, and potential competition in rare liver disease therapeutics. Mirum's long-term success depends on broadening patient reach, expanding its franchise through new approvals, and demonstrating sustained demand for its therapies. Listening to the earnings call will provide color on market penetration, payer dynamics, & management's strategy for growth. The next projected earnings date for MIRM is 11/3/2026 after close (stay tuned for a confirmed earnings date once announced).

MIRM Next Earnings Date FAQ

On this page we presented the MIRM Next Earnings Date information for Mirum Pharmaceuticals along with recent past earnings dates. For Q2 of 2026, MIRM reported earnings of -0.800/share, with the earnings report taking place on 8/5/2026. For Q1 of 2026, MIRM reported earnings of -0.500/share, with the earnings report taking place on 5/6/2026. For Q4 of 2025, MIRM reported earnings of -0.120/share, with the earnings report taking place on 2/25/2026. For Q3 of 2025, MIRM reported earnings of 0.050/share, with the earnings report taking place on 11/4/2025. For Q2 of 2025, MIRM reported earnings of -0.120/share, with the earnings report taking place on 8/6/2025. Based on these past earnings dates, the projected next earnings date for MIRM is 11/3/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Mirum Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Mirum Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Mirum Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next MIRM earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up MIRM's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the MIRM next earnings date.